Publication
Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene
| dc.contributor.author | Duarte, Ana Joana | |
| dc.contributor.author | Ribeiro, Diogo | |
| dc.contributor.author | Santos, Renato | |
| dc.contributor.author | Moreira, Luciana | |
| dc.contributor.author | Bragança, José | |
| dc.contributor.author | Amaral, Olga | |
| dc.date.accessioned | 2020-04-27T07:36:14Z | |
| dc.date.available | 2020-04-27T07:36:14Z | |
| dc.date.issued | 2019-10-18 | |
| dc.description | The authors thank Hildeberto Correia (Department of Human Genetics in Lisbon), for the karyotype analysis; José Ferrão (Department of Human Genetics in Lisbon), for the STR analysis; the collaboration of the central core services of Department of Human Genetics in Lisbon is acknowledge as well as Meghan Quint for assistance with English language. | pt_PT |
| dc.description.abstract | Gaucher Disease (GD) type 3 is a neurological form of a multisystemic autosomal recessive disorder belonging to the group of lysosomal storage diseases. Causal mutations in the glucocerebrosidase 1 (GBA1) commonly lead to abnormal protein and GD, heterozygosity is a genetic risk factor for Parkinson's disease. This work describes the use of a non-integrative approach using Sendai Virus delivery to establish induced Pluripotent Stem Cells (iPSCs) from fibroblasts from a GD type 3 patient. Differentiation of iPSCs can be employed to generate a variety of complex cell types with a high degree of genetic complexity that would otherwise be unattainable. | pt_PT |
| dc.description.sponsorship | This work was carried out at the Department of Human Genetics of INSA; financial support was received exclusively from the Portuguese Foundation of Science and Technology(FCT) project PTDC/BIM-MEC/4762/2014 (PI-O.A.) and R.S. is the recipient of an FCT Grant from project PTDC/BIM-MEC/4762/2014 (MCTES). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Stem Cell Res. 2019 Dec;41:101595. doi: 10.1016/j.scr.2019.101595. Epub 2019 Oct 18 | pt_PT |
| dc.identifier.doi | 10.1016/j.scr.2019.101595 | pt_PT |
| dc.identifier.issn | 1873-5061 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/6527 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier | pt_PT |
| dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S1873506119302259?via%3Dihub | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
| dc.subject | Gaucher Disease | pt_PT |
| dc.subject | Induced Pluripotent cells | pt_PT |
| dc.subject | Cell models | pt_PT |
| dc.subject | Gaucher type 3 | pt_PT |
| dc.subject | INSAi001-A | pt_PT |
| dc.subject | Disease Modelling | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.subject | Genética Humana | pt_PT |
| dc.title | Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.startPage | 101595 | pt_PT |
| oaire.citation.title | Stem Cell Research | pt_PT |
| oaire.citation.volume | 41 | pt_PT |
| person.familyName | Bragança | |
| person.familyName | Amaral | |
| person.givenName | José | |
| person.givenName | Olga | |
| person.identifier.ciencia-id | AC1D-FA9D-F66F | |
| person.identifier.ciencia-id | 6F1F-54A3-BBB9 | |
| person.identifier.orcid | 0000-0001-9566-400X | |
| person.identifier.orcid | 0000-0002-3478-2122 | |
| person.identifier.scopus-author-id | 6602220001 | |
| person.identifier.scopus-author-id | 7004054964 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 19dfd8e1-94b8-42b3-a811-f3e61540775c | |
| relation.isAuthorOfPublication | 8c7fb04a-80c0-4dd7-b3c5-682f6d25662b | |
| relation.isAuthorOfPublication.latestForDiscovery | 8c7fb04a-80c0-4dd7-b3c5-682f6d25662b |
